Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2021
Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing SorafenibGiovanni Marasco, Franco Trevisani,
Hepatology (Baltimore, Md.)|March 19, 2016
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?Franco Trevisani, Rita Golfieri
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2009
Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of NostradamusFranco Trevisani, Valentina Santi
The American Journal of Gastroenterology|June 6, 2013
Surveillance for hepatocellular carcinoma: just do it!Edoardo G Giannini, Franco Trevisani
Annals of Hepatology|October 24, 2021
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidenceFranco Trevisani, Edoardo G Giannini,
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2014
Accuracy of α-fetoprotein measurement in detection of hepatocellular carcinoma--1 more nail in the coffinEdoardo G Giannini, Franco Trevisani
Hepatobiliary Surgery and Nutrition|November 2, 2019
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoproteinEdoardo G Giannini, Franco Trevisani
Hepatology (Baltimore, Md.)|January 15, 2014
Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of careEdoardo G Giannini, Franco Trevisani
Annals of Internal Medicine|February 3, 2015
Screening for hepatocellular carcinoma in chronic liver diseaseEdoardo G Giannini, Franco Trevisani
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2017
Response to Intermediate stage treatment: Is TACE enough?Anna Pecorelli, Barbara Lenzi, Franco Trevisani, et al.
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2021
Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing SorafenibGiovanni Marasco, Franco Trevisani,
Hepatology (Baltimore, Md.)|March 19, 2016
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?Franco Trevisani, Rita Golfieri
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2009
Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of NostradamusFranco Trevisani, Valentina Santi
The American Journal of Gastroenterology|June 6, 2013
Surveillance for hepatocellular carcinoma: just do it!Edoardo G Giannini, Franco Trevisani
Annals of Hepatology|October 24, 2021
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidenceFranco Trevisani, Edoardo G Giannini,
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2014
Accuracy of α-fetoprotein measurement in detection of hepatocellular carcinoma--1 more nail in the coffinEdoardo G Giannini, Franco Trevisani
Hepatobiliary Surgery and Nutrition|November 2, 2019
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoproteinEdoardo G Giannini, Franco Trevisani
Hepatology (Baltimore, Md.)|January 15, 2014
Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of careEdoardo G Giannini, Franco Trevisani
Annals of Internal Medicine|February 3, 2015
Screening for hepatocellular carcinoma in chronic liver diseaseEdoardo G Giannini, Franco Trevisani
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2017
Response to Intermediate stage treatment: Is TACE enough?Anna Pecorelli, Barbara Lenzi, Franco Trevisani, et al.
Pageof 21